BIAF Stock Performance, Insider Transaction and News

BIAF - bioAffinity Technologies, Inc.

Market Cap	22.93M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-12.06M	Forward P/E	-	EPS next Y	-	50D Avg Chg	27.00%
Sales	2.46k	PEG	-	EPS past 5Y	-	200D Avg Chg	-1.00%
Dividend	N/A	Price/Book	1.82	EPS next 5Y	-	52W High Chg	-82.00%
Recommedations	-	Quick Ratio	9.23	Shares Outstanding	8.37M	52W Low Chg	109.00%
Insider Own	25.13%	ROA	-26.42%	Shares Float	5.31M	Beta	-
Inst Own	0.79%	ROE	-2,530.31%	Shares Shorted/Prior	32.94K/33.34K	Price	2.74
Gross Margin	88.12%	Profit Margin	-	Avg. Volume	1,325,262	Target Price	-
Oper. Margin	-124,015.78%	Earnings Date	-	Volume	153,462	Change	-4.20%

Healthcare | Diagnostics & Research | United States

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

bioAffinity Technologies, Inc. News

01/24/23	bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
01/04/23	bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments
12/19/22	Argus Research Initiates Equity Research Report Coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF)
12/15/22	bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench
12/01/22	bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
11/14/22	bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
11/10/22	bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
11/08/22	bioAffinity Technologies to Report Third Quarter 2022 Financial Results
10/25/22	bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia
10/12/22	bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
09/28/22	bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M
09/14/22	bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE
09/06/22	WallachBeth Capital Announces Closing Of bioAffinity Technologies, Inc. $7.8 Million Initial Public Offering
09/06/22	bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering
09/01/22	WallachBeth Capital Announce Pricing Of bioAffinity Technologies IPO At $6.125 Per Unit
09/01/22	bioAffinity Technologies Announces Pricing of IPO

BIAF Chatroom

Doctor1982 Posted - 1 hour ago

$BIAF Auvi Will go to 2.5 dollars 💵

shortablestocks Posted - 2 hours ago

$BIAF is short sale restricted for 2023-01-30. https://www.shortablestocks.com/?BIAF

dividendinvestorbyeagle Posted - 3 hours ago

$BIAF close increased > 10% (Bioaffinity Technologies Inc) https://www.dividendinvestor.com/dividend-news/?symbol=biaf

Petypete Posted - 18 hours ago

$BIAF what do we think about next week? any oracles here?:)

RagingStocks Posted - 18 hours ago

Oversold Big Boards sling shotting back to $$$$++++? ADAG AUD AVAH $BIAF BZFD CACO CLXT $FOXO $FRGT GETR GWAV HLLY KRKR LIDR LU $MULN $MYO PIII POL PRCH QTT SFR STRC TOI TSLA TTCF TUYA VATE VRM VVPR WISH WLDS WSRC

GSP Posted - 21 hours ago

Day Trading Watch List Video for January 30th: $BZFD $BIAF $LCID $CVNA $GTII Watch here: https://greatstockpix.com/january-30th-day-trading-watch-list/

saunderswe Posted - 1 day ago

$BIAF

TradeAlertsTeam Posted - 1 day ago

$BIAF Keep watch if this holds above 2.75 Watch 3.05 Break

ChartMill Posted - 1 day ago

$BIAF has an Altman-Z score of 6.36, meaning it is financially healthy with little risk of bankruptcy. https://www.chartmill.com/stock/quote/BIAF/fundamental-analysis?key=01bafb40-c7a0-467c-931c-d7d57ed1c4ec&utm_source=stocktwits&utm_medium=FA&utm_content=BIAF&utm_campaign=social_tracking

AlertsAndNews Posted - 1 day ago

$CABA $GROM $GNS $BIAF $LCID 📈✅ Let's keep the train rolling on Monday! Sunday watchlist will be out tomorrow. Enjoy the rest of your weekend! Hit that follow for more. All trading/investing involves a risk of loss. Do your own due diligence always!

CrytiCaII Posted - 2 days ago

$BIAF recent IPO that popped up again this week. Held up around 3 and we will have an eye on it next week for sure! Ran +80.9% after we mentioned it ✅

ChartMill Posted - 2 days ago

The Current Ratio of $BIAF is much better than the industry average of 6.16. https://www.chartmill.com/stock/quote/BIAF/fundamental-analysis?key=01bafb40-c7a0-467c-931c-d7d57ed1c4ec&utm_source=stocktwits&utm_medium=FA&utm_content=BIAF&utm_campaign=social_tracking

AlertsAndNews Posted - 2 days ago

What a week. Runners for all, $GNS $HLBZ $GROM $LCID $BIAF all 🎯 Have a great weekend, hit that follow! All trading/investing involves a risk of loss. Do your own due diligence always!